FLIP consortium, the FibroFrance Group, the EPIC-3 program and the QUID-NASH group

1 publications in the catalogue · 2020–2020

1 publications

Product

Diseases

Co-authors

  1. Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes.

    Poynard T et al. · Eur J Gastroenterol Hepatol · 2020

    FibroTest NashTest-2 SteatoTest-2 Metabolic